DIADIA0.48%
SPYSPY0.10%
QQQQQQ1.12%
Trending
Top trending tickerDJTDJT3.71%
BRK.ABRK.A1.14%
GSATGSAT0.33%
ALBALB1.76%
LTCLTC1.02%
SOLSOL1.48%
SHIBSHIB26.09%
AXSMAXSM0.22%
ETHETH2.10%
REPLREPL7.27%
Top trending tickerDJTDJT3.71%
BRK.ABRK.A1.14%
GSATGSAT0.33%
ALBALB1.76%
LTCLTC1.02%
SOLSOL1.48%
SHIBSHIB26.09%
AXSMAXSM0.22%
ETHETH2.10%
REPLREPL7.27%

Feed

News

Sentiment

Fundamentals

Info

homeSymbolOSRHnews
Exchange: NASDAQ·Updated 07:46 PM EDT
OSRH logo

OSRHOSR Health Inc.

$0.4228
$0.0272
(6.04%)
Today
Closed $0.4228
$0.0028
(0.66%)
After Hours
Mkt Cap$14.85M
Vol270,268.00
News
all
press releases
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers OSR Health (NASDAQ:OSRH) stock increased by 7.2% to $0.33 during Wednesday's after-market session. The company's market cap stands at $11.0 million. BioRestorative Therapies (NASDAQ:BRTX) stock movedread more...
Benzinga
More News
OSRH Stock Rockets 60% On $815M Immunotherapy Deal — Retail Bulls Eye $1 Mark For The Stock
The company signed a global licensing deal with BCM Europe that could bring in up to $815 million in milestone payments.
Stocktwits
OSR Holdings Stock Surges Over 41% After Hours: Why Is It Moving?
OSR Holdings shares surged 41.28% after securing a global exclusive licensing deal for its Phase 3-ready cancer immunotherapy VXM01, with potential milestone payments up to $815 million.read more...
Benzinga
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials
Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials Woori IO, an OSR Company, Signs NDA with Sinopharm for China Market and Global Multicenter Trials PR...
PR Newswire
Why Did OSRH Stock Jump 20% Today?
The company received an additional 180-day extension from Nasdaq to regain compliance after receiving an initial notice on Sept. 9, 2025.
Stocktwits
Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch
Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical...
PR Newswire
Vaximm Appoints Sbastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform
Vaximm Appoints Sbastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform Vaximm Appoints Sbastien Wieckowski, PhD, as Chief Scientific Officer to...
PR Newswire
Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones
Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones Vaximm, an OSR Company, Receives Binding Term...
PR Newswire
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings
Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings PR...
PR Newswire
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months
Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period...
PR Newswire
<
1
2
...
>

Advertisement|Remove ads.

Advertisement|Remove ads.